An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990's. Clin Microbiol Rev 2003;2:319–354.
von Reyn CF, Waddell RD, Eaton T, Arbeit RD, Maslow JN, Barber TW, Brindle RJ, Gilks CF, Lumio J, Lahdevirta J. et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol 1993;1:3227–3230.
Meissner G, Anz W. Sources of Mycobacterium avium-complex infection resulting in human disease. Am Rev Respir Dis 1977;116:1057–1064.
von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander R, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001;5:1122–1128.
Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99:1–132.
Good RC, Snider DE. Isolation of nontuberculous mycobacteria in the United States. J Infect Dis 1980;146:829–833.
O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987;135:1007–1014.
Horsburgh CR Jr. Epidemiology of disease caused by nontuberculous mycobacteria. Semin Respir Infect 1996;11:244.
Ahn CH, Wallace RJ Jr, Steele LC, Murphy DT. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii. Am Rev Respir Dis 1987;135:10–16.
Knapp CC, Body BA, Brown-Elliott BA, Holliday N, Hall GS, Tuohy MJ, Wilson D, Killian SB, Warshauer D, Wengenack N, et al. Mycobacterium peregrinum ATCC 700686 susceptibility testing: a multisite evaluation to establish microbroth dilution quality contol (QC) ranges for 5 antimicrobial agents [abstract C-020]. Abstr Annu Meet Am Soc Microbiol 2005;104.
Wolinsky E. State of the art: nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;110:107–l 59.
Hartman TE, Swensen SJ, Williams DE. Mycobacterium avium-intracellulare complex: evaluation with CT. Radiology 1973;17:23–26.
Primack SL, Logan PM, Hartman TE, Lee KS, Muller NL. Pulmonary tuberculosis and Mycobacterium avium-intracellulare: a comparison of CT findings. Radiology 1905;I94:413–417.
Patz EF, Swensen SJ, Erasmus J. Pulmonary manifestation of nontuberculous mycobacteria. Radiol Clin North Am 1995;33:719–729.
Olivier KN, Yankaskas JR, Knowles MR. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996;11:272–284.
Parker B, Ford M, Gruft H, Falkinham J. Epidemiology of infection by nontuberculous mycobacteria: IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis 1983;128:652–656.
Pelletier P, duMoulin G, Stottmeier K. Mycobacteria in public water supplies: comparative resistance to chlorine. Microbiol Sci 1988;5:147–148.
Centers for Disease Control and Prevention. Biopsy-confirmed hypersensitivity pneumonitis in automobile production workers exposed to metalworking fluids—Michigan, 1994–1995. MMWR Morb Mortal Wkly Rep 1996;45:606–610.
Centers for Disease Control and Prevention. Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria—Ohio, 2001. MMWR Morb Mortal Wkly Rep 2002;51:349–352.
Novick RJ, Moreno-Cabral CE, Stinson EB, Oyer PE, Starnes VA, Hunt SA, Shumway NE. Nontuberculous mycobacterial infections in heart transplant recipients: a seventeen-year experience. J Heart Transplant 1990;9:357–363.
Bottger EC. Mycobacterium genavense: an emerging pathogen. Eur J Clin Microbiol Infect Dis 1904;13:932–936.
Ausina VJ, Barrio M, Luquin M, Samhcat M, Gurgui G, Verger G, Prats G. Mycobacterium xenopi infections in the acquired immunodeficiency syndrome. Ann Intern Med 109:927–928.
Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae (chelonae): importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1982;166:405–412.
Lange CG, Lederman MM. Immune reconstitution with antiretroviral therapies in chronic HIV-I infection. J Antimicrob Chemother 2003;51:1–4.
Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis 1972;105:683–714.
Margileth AM, Chandra R, Altman P. Chronic lymphadenopathy due to mycobacterial infection. Am J Dis Child 1984;13:917–922.
Henriques B, Hoffner SE, Petrini B, Juhlin L, Wahlen P, Kallenius G. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994;18:1596–1600.
Baily TM, Akhtar M, Ali MA. Fine needle aspiration biopsy in the diagnosis of tuberculosis. Acta Cytol 1985;29:732–736.
Gupta SK, Chugh TD, Sheikh ZA, Al-Rubah NA. Cytodiagnosis of tuberculosis lymphadenitis. Acta Cytol 1993;37:329–332.
Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968;97:1032–1037.
Szabo I. Mycobacterium chelonei endemy after heart surgery with fatal consequences. Am Rev Respir Dis 1980;121:607.
Laussucq S, Baltch AL, Smith RP, Smithwick RW, Davis BJ, Desjardin EK, Silcox VA, Spellacy AB, Zeimis R, Gruft HM, et al. Nosocomial Mycobacteriium fortuitum colonization from a contaminated ice machine. Am Rev Respir Dis 1988;132:891–894.
Kuritsky JN, Bullen M, Broome CV, Silcox V, Good R, Wallace RJ Jr. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex: a potential environmental source. Ann Intern Med 1983;9:938–939.
Safranek TJ, Jarvis WT, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1997;317:197–201.
Wenger JD, Spika JS, Smithwick RW, Pryor V, Dodson DW, Carden GA, Klontz KC. Outbreak of Mycobacterium chelonae infection associated with use of jet injectors. JAMA 1990;1264:373–376.
Wallace RJ Jr, Zhang Y, Brown BA, Fraser V, Mazurck G, Maloney S. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol 1993;3:2697–2701.
Chan ED, Kong PM, Fennelly K, Dwyer AP, Iseman MD. Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: three examples of the principle of locus minoris resistentia. Clin Infect Dis 2001;31:1506–1510.
Boian MG, Aronson TW, Holtzman AE, Bishop N, Tran TT, Glover N, Berlin OW, Stelma GN Jr, Froman S. A comparison of clinical and potable water isolates of Mycobacterium avium using PCR of genomic sequences between insertion elements [abstract U-161]. Abstr Gen Meet Am Soc Microbiol 1997;571.
Centers for Disease Control and Prevention. Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract: Colorado and Wyoming. MMWR Morb Mortal Wkly Rep 1996;45:713–715.
Centers for Disease Control and Prevention. Mycobacterium chelonae infections associated with facelifts: New Jersey, 2002–2003. MMWR Morb Mortal Wkly Rep 2004;53:192–194.
Hogg GG, Schinsky MF, McNeil MM, Lasker BA, Silcox VA, Brown JM. Central line sepsis in a child due to a previously unidentified mycobacterium. J Clin Microbiol 1994;37:1193–1196.
Franklin DJ, Starke JR, Brady MT, Brown BA, Wallace RJ Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am J Otol 1994;3:313–320.
Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res 1987;216:183–187.
Steere AC, Corrales J, von Graevenitz A. A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Am Rev Respir Dis 1979;120:214–216.
Bennett SN, Peterson DE, Johnson DR, Hall WN, Robinson-Dunn B, Dietrich S. Bronchoscopy-associated Mycobacterium xenopi pseudoinfections. Am J Respir Crit Care Med 1984;150:245–250.
Maloney S, Welbel S, Daves B, Adams K, Becker S, et al. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemologic and laboratory administration. J Infect Dis 1994;169:166–169.
Ahn CH, McLarty IW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125:388–391.
The Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up patients receiving standardized treatment. Int J Tuberc Lung Dis 2002;67:628–634.
Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1986;134:438–441.
Seibert AF, Bass JB. Four drug therapy of pulmonary disease due to Mycobacterium avium complex [abstract]. Presented at the 1989 Annual Meeting of American Thoracic Society, May 14–17, Cincinnati, OH. Am Rev Respir Dis 1994;139(Suppl):A399.
Yeager H Jr, Raleigh JW. Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis 1973;108:547–552.
Horsburgh CR Jr, Mason UG, Heifets LB III, Southwick K, Labrecque J, Iseman MD. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis 1987;135:418–421.
Kanatani MS, Guglielmo BJ. The new macrolides: azithromycin and clarithromycin. West J Med 1994;160:31–37.
Eisenberg E, Barza M. Azithromycin and clarithromycin. Curr Clin Top Infect Dis Chest 1994;14:52–79.
Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000;302:288–292.
Woodley CL, Kilburn JO. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis 1982;126:586–587.
Parrot RG, Grosset JH. Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. Tubercle 1991;69:47–55.
Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons. MMWR Morb Mortal Wkly Rep 2002;51:1–52.
Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace PM, Greer DL, Hyslop NE Jr. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1996;22:1130–1131.
Baily RK, Wyles S, Dingley M, Hesse F, Kent GW. The isolation of high catalase Mycobacterium kansasii from tap water. Am Rev Respir Dis 1970;101:430–431.
Levy-Frebault V, David HL. Mycobacterium kansasii: drinking water contaminant of a hospital. Rev Epidemiol Sante Publique 1983;31:11–20.
Corbett EL, Hay M, Churchyard GJ, Herselman P, Clayton T, Williams BG, Hayes R, Mulder D, De Cock KM. Mycobacterium kansasii and Mycobacterium scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 1999;3:501.
Francis PB, Jay SJ, Johanson WG Jr. Course of un-treated Mycobacterium kansasii disease. Am Rev Respir Dis 1975;111:477–487.
Wallace RJ Jr, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy D. Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 1994;I8:1736–1743.
Hobby GL, Redmond WB, Runyon EH, Schaefer WB, Wayne LG, Wichelhausen RH. A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. Am Rev Respir Dis 1967;95:954–971.
Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hurst GA. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983;128:1048–1050.
Thomsen VO, Dragsted UB, Bauer J, Fuursted K, Lundgren J. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol 1999;7:3901–3905.
Fournier S, Vincent V. Mycobacterium genavense and cutaneous disease in AIDS. Ann Intern Med 1998;128:409.
Rasogi N, Goh KS, Guillou N, Labrousse V. Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs? Int J Med Microbiol Virol Parasitol Infect Dis 1992;277:474–484.
Wolinsky E, Gomez F, Zimpfer F. Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol. Am Rev Respir Dis 1972;105:964–967.
Sanders JW, Walsh AD, Snider RL, Sahn EE. Disseminated Mycobacterium scrofulaceum infection: a potentially treatable complication of AIDS. Clin Infect Dis 1995;30:444–453.
Wallace RJ Jr, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA. Human disease due to Mycobacterium smegmatis. J Infect Dis 1980;158:52–59.
Tsuyuguchi K, Amitani R, Matsumoto H, Tanaka E, Suzuki K, Yanagihara K, Mizuno H, Hitomi S, Kuze K. A resected case of Mycobacterium szulgai pulmonary disease. Int J Tuberc Lung Dis 1998;2:258–260.
Kuze FA, Mitsuoka W, Chiba Y, Shimizu MI, Teramatsu NM, Suzuki Y. Chronic pulmonary infection caused by Mycobacterium terrae complex: a resected case. Am Rev Respir Dis 1993;128:561–565.
van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, Fleischer B, Wansbrough-Jones MH, Johnson PD, Portaels F, van der Graaf WT, et al. Mycobacterium ulcerans disease. Bull World Health Organ 2005;83:785–791.
Gross WM, Hawkins JE, Murphy DB. Origin and significance of Mycobacterium xenopi in clinical specimens. Bull Int Union Tuberc Lung Dis 1976;51:267–269.
Costrini AM, Mahler DA, Gross WM, Hawkins JE, Yesner R, D'Esopo D. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 1981;123:104–109.